| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |